Literature DB >> 24244803

The Impact of Health Insurance Policy Changes on Californians with Severe Chronic Disease.

Arleen A Leibowitz1, Katherine Desmond.   

Abstract

Two recent changes in health policy will likely negatively impact state budgets and the health of low-income Californians with chronic disease. The new cost-sharing for medical visits, pharmaceuticals, and inpatient stays in California's Medcaid program (Medi-Cal) and the exclusion of the undocumented and individuals who have been legal residents for less than five years from the insurance expansions that The Patient Protection and Affordable Care Act of 2010 provides will reduce medical care utilization and may raise, rather than lower, state costs. Based on historical Medi-Cal utilization patterns, people living with HIV (PLWH) would average $514 in cost-sharing fees annually. The undocumented may lose coverage entirely and face even higher costs. The charges are high relative to the low incomes of both Medi-Cal recipients and the undocumented and are likely to discourage relatively inexpensive, but productive, medical care. Increasing patient costs harms patient health, harms public health, and increases state spending on medical care.

Entities:  

Keywords:  Affordable Care Act; Medicaid; Medicare; health insurance; health policy

Year:  2011        PMID: 24244803      PMCID: PMC3828734          DOI: 10.2202/1944-4370.1174

Source DB:  PubMed          Journal:  Calif J Politics Policy        ISSN: 1944-4370


  19 in total

1.  Cost-sharing for emergency care and unfavorable clinical events: findings from the safety and financial ramifications of ED copayments study.

Authors:  John Hsu; Mary Price; Richard Brand; G Thomas Ray; Bruce Fireman; Joseph P Newhouse; Joseph V Selby
Journal:  Health Serv Res       Date:  2006-10       Impact factor: 3.402

2.  Evidence that value-based insurance can be effective.

Authors:  Michael E Chernew; Iver A Juster; Mayur Shah; Arnold Wegh; Stephen Rosenberg; Allison B Rosen; Michael C Sokol; Kristina Yu-Isenberg; A Mark Fendrick
Journal:  Health Aff (Millwood)       Date:  2010-01-21       Impact factor: 6.301

3.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

4.  Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.

Authors:  S A Bozzette; G Joyce; D F McCaffrey; A A Leibowitz; S C Morton; S H Berry; A Rastegar; D Timberlake; M F Shapiro; D P Goldman
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

5.  Emergency department use and subsequent hospitalizations among members of a high-deductible health plan.

Authors:  J Frank Wharam; Bruce E Landon; Alison A Galbraith; Ken P Kleinman; Stephen B Soumerai; Dennis Ross-Degnan
Journal:  JAMA       Date:  2007-03-14       Impact factor: 56.272

6.  Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.

Authors:  Dana P Goldman; Geoffrey F Joyce; Pinar Karaca-Mandic
Journal:  Am J Manag Care       Date:  2006-01       Impact factor: 2.229

7.  Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Authors:  Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

8.  Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial.

Authors:  William Burman; Birgit Grund; Jacqueline Neuhaus; John Douglas; Gerald Friedland; Edward Telzak; Robert Colebunders; Nicholas Paton; Martin Fisher; Cornelis Rietmeijer
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

Review 9.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

10.  Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors:  S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.